Navigation

Investiment.io
Financial analysis platform

Abbott Laboratories

ABT โ€ข NYSE

$107.45
โ–ผ1.07 (0.99%)โ€ข REGULAR

Abbott Laboratories

$107.45
โ–ผ1.0%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading
๐Ÿ“Š

Key Metrics & ValuationABT

Cash Flow Summary

Key cash flow metrics and liquidity indicators for ABT

๐Ÿ“Š
P/E Ratio
28.81
(Price-to-Earnings)
๐Ÿ“ˆ
ROE
12.5%
(Return on Equity)
๐Ÿ’ง
Current Ratio
1.58
(Liquidity)
โš–๏ธ
Debt-to-Equity
0.25
(Leverage)
๐Ÿ’ฐ
Dividend Yield
2.3%
(Annual Yield)
๐Ÿข
Market Cap
$187,950,303
(in thousands)

Key Metrics Analysis

Analyze key financial ratios and valuation metrics over time

Period:annual

Select Metrics to Compare (4 selected)

P/E Ratio Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 20250.009.0018.0027.0036.00-110%-55%0%+55%+110%
  • P/E Ratio
  • P/E Ratio YoY Growth

Return on Equity (ROE) Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$0.00K$0.00K$0.00K$0.00K-90%-45%0%+45%+90%
  • Return on Equity (ROE)
  • Return on Equity (ROE) YoY Growth

Current Ratio Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 20250.000.501.001.502.00-12%-8%-4%0%+4%
  • Current Ratio
  • Current Ratio YoY Growth

Debt-to-Equity Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 20250.000.150.300.450.60-24%-20%-16%-12%-8%
  • Debt-to-Equity
  • Debt-to-Equity YoY Growth